Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial.
Saved in:
| Title: | Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial. |
|---|---|
| Authors: | Nicholls SJ; Victorian Heart Institute, Monash University, 631 Blackburn Road, Clayton, VIC, 3168, Australia. stephen.nicholls@monash.edu., Ray KK; Imperial College London, London, UK., Lincoff AM; Cleveland Clinic, Cleveland, OH, USA., Sarnes E; Esperion Therapeutics, Ann Arbor, MI, USA., Gillard KK; Esperion Therapeutics, Ann Arbor, MI, USA., Bloedon L; Esperion Therapeutics, Ann Arbor, MI, USA., Migliaccio-Walle K; Curta Inc., Seattle, WA, USA., Elsea D; Curta Inc., Seattle, WA, USA., Nissen SE; Cleveland Clinic, Cleveland, OH, USA. |
| Source: | American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2026 Jan; Vol. 26 (1), pp. 59-70. Date of Electronic Publication: 2025 Aug 20. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-187X |
|---|---|
| DOI: | 10.1007/s40256-025-00753-w |
